Last Updated: 31/01/2025

ImmunoCoV: Host immune responses to SARS-CoV-2

Objectives

Host immune responses to SARS-CoV-2: correlating kinetics with the natural history of infection.

Aims to:

  1. Test and validate antibody and other immunological assays for the diagnosis and further research on the immunology of SARS-CoV-2 infections in African populations, and
  2. Provide detailed kinetics of the immune response to SARS-CoV-2 in relation to viral shedding, clinical symptoms and asymptomatic infections 
Principal Investigators / Focal Persons

Francis Ndung’u

Themes

Surveillance

Date

Jul 2020 — Jul 2022

Total Project Funding

$607,070

Project Site

Kenya

SHARE
SHARE